Home Experimental cholesterol drugs cut heart risk, but questions remain
 

Keywords :   


Experimental cholesterol drugs cut heart risk, but questions remain

2015-03-15 22:33:26| Biotech - Topix.net

Studies of a new class of experimental cholesterol-lowering drugs signal that they may reduce by half the risk of heart attack and other major cardiovascular problems compared to standard treatment alone. San Diego: Studies of a new class of experimental cholesterol-lowering drugs signal that they may reduce by half the risk of heart attack and other major cardiovascular problems compared to standard treatment alone.

Tags: questions heart risk cut

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
14.05Recovery resources available for Texas livestock producers
14.05About-Face and AF94 Appoint Francesca Raminella as New CEO
14.05An unraveled genetic mystery in Angus
14.05Is HPAI a risk to beef cattle?
14.05Fresh Partners with Juno Shen on Limited-Edition Kombucha Facial Treatment Essence
More »